NVRO
Price
$3.84
Change
-$0.21 (-5.19%)
Updated
Dec 18, 04:25 PM (EDT)
63 days until earnings call
TNDM
Price
$33.69
Change
-$0.54 (-1.58%)
Updated
Dec 18, 04:33 PM (EDT)
63 days until earnings call
Ad is loading...

NVRO vs TNDM

Header iconNVRO vs TNDM Comparison
Open Charts NVRO vs TNDMBanner chart's image
NEVRO
Price$3.84
Change-$0.21 (-5.19%)
Volume$300
CapitalizationN/A
Tandem Diabetes Care
Price$33.69
Change-$0.54 (-1.58%)
Volume$8.45K
CapitalizationN/A
NVRO vs TNDM Comparison Chart
Loading...
NVRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVRO vs. TNDM commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVRO is a Hold and TNDM is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (NVRO: $4.05 vs. TNDM: $34.23)
Brand notoriety: NVRO and TNDM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVRO: 121% vs. TNDM: 69%
Market capitalization -- NVRO: $525.59M vs. TNDM: $2.32B
NVRO [@Medical Specialties] is valued at $525.59M. TNDM’s [@Medical Specialties] market capitalization is $2.32B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVRO’s FA Score shows that 0 FA rating(s) are green whileTNDM’s FA Score has 0 green FA rating(s).

  • NVRO’s FA Score: 0 green, 5 red.
  • TNDM’s FA Score: 0 green, 5 red.
According to our system of comparison, TNDM is a better buy in the long-term than NVRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVRO’s TA Score shows that 5 TA indicator(s) are bullish while TNDM’s TA Score has 7 bullish TA indicator(s).

  • NVRO’s TA Score: 5 bullish, 5 bearish.
  • TNDM’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, TNDM is a better buy in the short-term than NVRO.

Price Growth

NVRO (@Medical Specialties) experienced а -6.68% price change this week, while TNDM (@Medical Specialties) price change was +1.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.17%. For the same industry, the average monthly price growth was +1.60%, and the average quarterly price growth was -0.66%.

Reported Earning Dates

NVRO is expected to report earnings on Feb 19, 2025.

TNDM is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (-4.17% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNDM($2.32B) has a higher market cap than NVRO($526M). TNDM has higher P/E ratio than NVRO: TNDM (666.67) vs NVRO (147.06). TNDM YTD gains are higher at: 15.720 vs. NVRO (-81.180). NVRO has higher annual earnings (EBITDA): -78.31M vs. TNDM (-196.97M). TNDM has more cash in the bank: 468M vs. NVRO (323M). NVRO has less debt than TNDM: NVRO (216M) vs TNDM (416M). TNDM has higher revenues than NVRO: TNDM (748M) vs NVRO (425M).
NVROTNDMNVRO / TNDM
Capitalization526M2.32B23%
EBITDA-78.31M-196.97M40%
Gain YTD-81.18015.720-516%
P/E Ratio147.06666.6722%
Revenue425M748M57%
Total Cash323M468M69%
Total Debt216M416M52%
FUNDAMENTALS RATINGS
NVRO vs TNDM: Fundamental Ratings
NVRO
TNDM
OUTLOOK RATING
1..100
5916
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
9153
P/E GROWTH RATING
1..100
9894
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVRO's Valuation (84) in the Medical Specialties industry is in the same range as TNDM (99). This means that NVRO’s stock grew similarly to TNDM’s over the last 12 months.

NVRO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TNDM (100). This means that NVRO’s stock grew similarly to TNDM’s over the last 12 months.

NVRO's SMR Rating (95) in the Medical Specialties industry is in the same range as TNDM (97). This means that NVRO’s stock grew similarly to TNDM’s over the last 12 months.

TNDM's Price Growth Rating (53) in the Medical Specialties industry is somewhat better than the same rating for NVRO (91). This means that TNDM’s stock grew somewhat faster than NVRO’s over the last 12 months.

TNDM's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as NVRO (98). This means that TNDM’s stock grew similarly to NVRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVROTNDM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
71%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
NVRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNDM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DREGX38.06N/A
N/A
Driehaus Emerging Markets Growth Inv
TCMGX21.41N/A
N/A
Nuveen Mid Cap Growth A
TORYX53.40-0.29
-0.54%
Torray Fund
SGIIX68.87-0.44
-0.63%
First Eagle Global I
LGCRX16.96-0.12
-0.72%
Lord Abbett Global Equity R3

NVRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVRO has been loosely correlated with INSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NVRO jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVRO
1D Price
Change %
NVRO100%
-2.41%
INSP - NVRO
47%
Loosely correlated
+1.00%
AZTA - NVRO
46%
Loosely correlated
+4.09%
CRL - NVRO
46%
Loosely correlated
-0.39%
NVST - NVRO
40%
Loosely correlated
-1.69%
SIBN - NVRO
38%
Loosely correlated
+0.51%
More

TNDM and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNDM has been loosely correlated with NVRO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TNDM jumps, then NVRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNDM
1D Price
Change %
TNDM100%
+1.94%
NVRO - TNDM
38%
Loosely correlated
-2.41%
MMSI - TNDM
33%
Loosely correlated
-3.24%
AZTA - TNDM
32%
Poorly correlated
+4.09%
FLGT - TNDM
32%
Poorly correlated
-1.12%
TWST - TNDM
32%
Poorly correlated
-0.06%
More